A low-risk depth move that adds rotational interior line presence for New England. Headlines highlight an improbable journey, including a Super Bowl LX appearance, suggesting surprising upside. His practice squad origins and waiver wire history signal he's a fringe roster player, not a long-term solution. Fans are intrigued by the underdog narrative but tempered in expectations given his marginal pedigree. Pharms Jr. projects as a camp-to-roster bubble player who must earn snaps through consistency.
📰5 news
Contract Value Index (CVI)
B-
Good Value
OverpayFair ValueGreat Value
This signing grades out as about market rate for the New England Patriots — the team is getting approximately what they're paying for in on-field production. Jeremiah's on-field performance ranks in the bottom third among NFL DTs, grading him as a depth piece at the position. His $1.0M average annual value ranks as bargain money for the DT market. The production-to-cost ratio is favorable — depth piece output at a bargain price point represents solid asset management. Jeremiah is squarely in his prime, which adds to the deal's upside — the team should get multiple productive seasons out of this contract. The one-year deal minimizes the team's financial risk, effectively making this a prove-it contract.
Contract Details
Length
1 year
Total Value
$1.0M
AAV
$1.0M
Guaranteed
$328K
Fan Verdict
Cast your verdict:
No fan votes yet. Be the first!
News & Buzz
Live Discussion
Auto-moderated fan forum with 5-minute speaker turns
